DUBLIN, April 20, 2016 /PRNewswire/ -- Allergan plc
(NYSE: AGN) today announced that it intends to release first
quarter 2016 financial results on Tuesday,
May 10, 2016, prior to the open of the U.S. financial
markets. The Company will host a conference call and webcast at
8:30 a.m. Eastern Time on
Tuesday, May 10, 2016 to discuss its
financial results. The dial-in number to access the call is
U.S./Canada (877) 251-7980,
International (706) 643-1573, and the conference ID is
94452083.
Logo -
http://photos.prnewswire.com/prnh/20150612/222796LOGO
A taped replay of the conference call will also be available
beginning approximately two hours after the call's conclusion and
will remain available through 11:30 PM
Eastern Time on May 24, 2016.
The replay may be accessed by dialing (855) 859-2056 and entering
conference ID 94452083. From international locations, the
replay may be accessed by dialing (404) 537-3406 and entering the
same conference ID. To access the webcast, go to Allergan's
Investor Relations Web site at http://ir.allergan.com. A replay of
the webcast will also be available.
About Allergan
Allergan plc (NYSE: AGN), headquartered in Dublin,
Ireland, is a unique, global
pharmaceutical company and a leader in a new industry model –
Growth Pharma. Allergan is focused on developing,
manufacturing and commercializing innovative branded
pharmaceuticals and biologic products for patients around the
world.
Allergan markets a portfolio of best-in-class products that
provide valuable treatments for the central nervous system, eye
care, medical aesthetics, gastroenterology, women's health,
urology, cardiovascular and anti-infective therapeutic categories,
and operates the world's third-largest global generics business,
providing patients around the globe with increased access to
affordable, high-quality medicines. Allergan is an
industry leader in research and development, with one of the
broadest development pipelines in the pharmaceutical industry and a
leading position in the submission of generic product applications
globally.
With commercial operations in approximately 100
countries, Allergan is committed to working with
physicians, healthcare providers and patients to deliver innovative
and meaningful treatments that help people around the world live
longer, healthier lives.
For more information, visit Allergan's website
at www.allergan.com.
Forward-Looking Statement
Statements contained in this press release that refer to future
events or other non-historical facts are forward-looking statements
that reflect Allergan's current perspective of existing trends and
information as of the date of this release. Except as expressly
required by law, Allergan disclaims any intent or obligation to
update these forward-looking statements. Actual results may differ
materially from Allergan's current expectations depending upon a
number of factors affecting Allergan's business. These factors
include, among others, the difficulty of predicting the timing or
outcome of FDA approvals or actions, if any; the impact of
competitive products and pricing; market acceptance of and
continued demand for Allergan's products; difficulties or delays in
manufacturing; and other risks and uncertainties detailed in
Allergan's periodic public filings with the Securities and Exchange
Commission, including but not limited to Allergan's Annual Report
on Form 10-K for the year ended December 31,
2015 (certain of such periodic public filings having been
filed under the "Actavis plc" name). Except as expressly required
by law, Allergan disclaims any intent or obligation to update these
forward-looking statements.
CONTACTS:
|
|
|
Investors:
|
|
Lisa
DeFrancesco
|
|
(862)
261-7152
|
|
|
|
Media:
|
|
Mark
Marmur
|
|
(862)
261-7558
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/allergan-to-host-first-quarter-2016-earnings-conference-call-and-webcast-300254260.html
SOURCE Allergan plc